Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancerMishra, A.; Parish, C.; Wong, M.; Licinio, J.; Blackburn, A.; Ahmad, A.
2017The combination of metformin and valproic acid induces synergistic apoptosis in the presence of p53 and androgen signaling in prostate cancerTran, L.N.; Kichenadasse, G.; Butler, L.M.; Centenera, M.M.; Morel, K.L.; Ormsby, R.J.; Michael, M.Z.; Lower, K.M.; Sykes, P.J.
2014Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingPishas, K.; Neuhaus, S.; Clayer, M.; Schreiber, A.; Lawrence, D.; Perugini, M.; Whitfield, R.; Farshid, G.; Manavis, J.; Chryssidis, S.; Mayo, B.; Haycox, R.; Ho, K.; Brown, M.; D'Andrea, R.; Evdokiou, A.; Thomas, D.; Desai, J.; Callen, D.; Neilsen, P.
2012Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cellsLipka, D.; Wagner, M.; Dziadosz, M.; Schnoder, T.; Heidel, F.; Schemionek, M.; Vaz de Melo, J.; Kindler, T.; Muller-Tidow, C.; Koschmieder, S.; Fischer, T.; Fields, A.P.
2013Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitorsWaibel, M.; Solomon, V.; Knight, D.; Ralli, R.; Kim, S.; Banks, K.; Vidacs, E.; Virely, C.; Sia, K.; Bracken, L.; Collins-Underwood, R.; Drenberg, C.; Ramsey, L.; Meyer, S.; Takiguchi, M.; Dickins, R.; Levine, R.; Ghysdael, J.; Dawson, M.; Lock, R.; et al.
2018Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma with SP-2509 engages the endoplasmic reticulum stress responsePishas, K.I.; Drenberg, C.D.; Taslim, C.; Theisen, E.R.; Johnson, K.M.; Saund, R.S.; Pop, I.L.; Crompton, B.D.; Lawlor, E.R.; Tirode, F.; Mora, J.; Delattre, O.; Beckerle, M.C.; Callen, D.F.; Sharma, S.; Lessnick, S.L.